Squarepoint Ops LLC Adma Biologics, Inc. Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 71,698 shares of ADMA stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,698

Previous 285,363 74.87%

Holding current value

$1.1 Million

Previous $5.66 Million 76.95%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 27, 2025	SELL	$17.6 - $24.51 $3.76 Million - $5.24 Million	-213,665 Reduced 74.87%	71,698 $1.31 Million
Q2 2025 Aug 14, 2025	SELL	$17.6 - $24.51 $3.76 Million - $5.24 Million	-213,665 Reduced 74.87%	71,698 $1.31 Million
Q1 2025 Aug 27, 2025	BUY	$15.44 - $20.61 $3.3 Million - $4.4 Million	213,665 Added 298.01%	285,363 $5.66 Million
Q1 2025 May 15, 2025	SELL	$15.44 - $20.61 $38,615 - $51,545	-2,501 Reduced 0.87%	285,363 $5.66 Million
Q4 2024 Feb 14, 2025	SELL	$15.62 - $22.62 $1.05 Million - $1.53 Million	-67,424 Reduced 18.98%	287,864 $4.94 Million
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $23,451 - $41,902	2,092 Added 0.59%	355,288 $7.1 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $831,040 - $1.55 Million	138,970 Added 64.87%	353,196 $3.95 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $215,564 - $330,206	-48,992 Reduced 18.61%	214,226 $1.41 Million
Q4 2023 Feb 14, 2024	BUY	$3.08 - $4.52 $680,581 - $998,775	220,968 Added 523.0%	263,218 $1.19 Million
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $131,820 - $178,295	42,250 New	42,250 $155,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $72,454 - $113,815	29,334 New	29,334 $113,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $257,394 - $395,991	-179,996 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $187,342 - $267,840	146,361 Added 435.14%	179,996 $329,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $63,537 - $96,763	-58,291 Reduced 63.41%	33,635 $47,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $228,184 - $333,189	-201,933 Reduced 68.72%	91,926 $104,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.07 $425,013 - $582,634	-281,466 Reduced 48.92%	293,859 $470,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $756,550 - $1.34 Million	453,024 Added 370.42%	575,325 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$1.8 - $2.56 $188,271 - $267,763	104,595 Added 590.73%	122,301 $238,000
Q3 2020 Nov 16, 2020	SELL	$2.04 - $3.74 $125,945 - $230,900	-61,738 Reduced 77.71%	17,706 $42,000
Q2 2020 Aug 14, 2020	BUY	$2.42 - $3.29 $146,318 - $198,919	60,462 Added 318.52%	79,444 $233,000
Q1 2020 May 15, 2020	SELL	$1.5 - $4.59 $20,365 - $62,318	-13,577 Reduced 41.7%	18,982 $55,000
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $126,654 - $167,678	32,559 New	32,559 $130,000
Q4 2018 Feb 14, 2019	SELL	$2.17 - $6.12 $25,172 - $70,992	-11,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.39 - $6.85 $2,432 - $3,794	554 Added 5.02%	11,600 $72,000
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $48,491 - $60,090	11,046 New	11,046 $50,000

Others Institutions Holding ADMA

# of Institutions

399

Shares Held

191M

Call Options Held

2.08M

Put Options Held

1.56M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Adma Biologics, Inc. Transaction History